Contact information
01865281639
The Peter Medawar Building for Pathogen Research
he/him/his
Colleges
Gerardo Montalvo Zurbía Flores
DPhil, MSc, BSc (Hons)
Postdoctoral Scientist
Virology | Immunology | Vaccinology
BIOGRAPHY
After undertaking a MSc in Medical Virology at the University of Manchester, I completed a DPhil in Clinical Medicine at the Jenner Institute (Nuffield Department of Medicine). During the DPhil, my research focused on the development of vaccines against mosquito-borne diseases such as dengue virus, Zika virus, chikungunya virus, and yellow fever virus; particularly, working towards the development of strategies for the generation of novel multi-disease vaccines using viral vectors.
RESEARCH INTERESTS
My research is primarily focused on medical virology and translational vaccinology. My current interests are the development of prophylactic Hepatitis C vaccines and universal coronavirus vaccines using viral vectors and mRNA. I employ bioinformatics and in-silico research to design ‘state-of-the-art’ vaccines, which then are tested in preclinical studies to determine their immunogenic potential. Besides the initial assessment of their immunogenicity, the research interests of the Barnes Group also include the immunological assessment of vaccine candidates in human clinical studies.
Collaborators
-
Paul Klenerman
Sidney Truelove Professor of Gastroenterology
Recent publications
Adapting in-cell ELISA to investigate the localization of hepatitis C virus envelope glycoproteins.
Journal article
Dimitriadis S. et al, (2026), Microbiology spectrum
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies
Journal article
Strain R. et al, (2026), Hepatology, 83, 1540 - 1556
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives.
Journal article
Pagliari S. et al, (2023), Journal of molecular biology, 435
Chikungunya Virus: Priority Pathogen or Passing Trend?
Journal article
Montalvo Zurbia-Flores G. et al, (2023), Vaccines, 11